產品詳情
簡單介紹：
Anti-LRCH4/LRRN1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-LRCH4/LRRN1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-LRCH4/LRRN1
Cat. Number:
Anti-LRCH4/LRRN1抗體KL-9330R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Members of the leucine-rich repeat family include LRCH1, LRCH2, LRCH3 and LRCH4. All family members contain one calponin-homology domain and nine leucine-rich repeats. LRCH4 (leucine-rich repeats and calponin homology (CH) domain containing 4), also known as LRN, LRRN1, LRRN4 or SAP25, is a 683 amino acid Anti-LRCH4/LRRN1抗體protein that belongs to the leucine-rich repeat family. The carboxy-terminus of LRCH4 may act as a membrane anchor between cells, while the amino-terminus contains the leucine-rich domains, which is thought to be involved in ligand binding. The calponin homology (CH) domain is suggested to confer Actin binding to a variety of cytoskeletal and signaling molecules. The gene encoding LRCH4 maps to human chromosome 7, which houses over 1,000 genes and comprises nearly 5% of the human genome.
Also known as:
Leucine rich repeat neuronal Anti-LRCH4/LRRN1抗體protein 4; Leucine rich repeats and calponin homology (CH) domain containing 4; Leucine-rich neuronal protein; LRN; LRRN1; LRRN4; PP14183; SAP25; Sin3 associated polypeptide, 25kDa; LRCH4_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Anti-LRCH4/LRRN1抗體Rat, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human LRCH4.
●
Predicted Molecular Weight: 73kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-LRCH4/LRRN1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-LRCH4/LRRN1抗體
Optimal working dilutions must be determined by the end user.
